Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,854 | 4,820 | 6,429 | 3,447 | 282 |
| Income taxes - deferred | 0 | 169 | -1,099 | -24 | N/A |
| Accounts receivable | -386 | 722 | 10,496 | -4,845 | -549 |
| Accounts payable and accrued liabilities | -6,420 | 3,614 | 1,383 | 6,222 | -879 |
| Other Working Capital | -7,292 | 6,335 | 12,980 | -1,065 | -1,822 |
| Other Operating Activity | -5,863 | -26,162 | -54,958 | -32,824 | -4,849 |
| Operating Cash Flow | $-17,107 | $-10,502 | $-24,768 | $-29,089 | $-7,816 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -744 | -2,956 | -22,674 | -18,217 | -2,257 |
| Net Acquisitions | 20,522 | 58,705 | -20,010 | -41,797 | -16,230 |
| Purchase Of Investment | -64 | N/A | 0 | 0 | -250 |
| Sale Of Investment | 383 | 206 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -92 | -522 | -1,442 | -465 | 0 |
| Other Investing Activity | -388 | -1,042 | 0 | -2,000 | -196 |
| Investing Cash Flow | $19,617 | $54,391 | $-44,126 | $-62,479 | $-18,933 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 40 | 24,217 | N/A | N/A |
| Debt Repayment | -612 | -25,792 | -3,067 | -92 | N/A |
| Common Stock Issued | 0 | 5,600 | 22,769 | 60,600 | 40,941 |
| Other Financing Activity | -9,384 | -264 | -8,542 | 22,579 | 27,114 |
| Financing Cash Flow | $-9,996 | $-20,416 | $35,377 | $83,087 | $68,055 |
| Beginning Cash Position | 25,998 | 2,525 | 36,042 | 44,523 | 3,217 |
| End Cash Position | 18,512 | 25,998 | 2,525 | 36,042 | 44,523 |
| Net Cash Flow | $-7,486 | $23,473 | $-33,517 | $-8,481 | $41,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,107 | -10,502 | -24,768 | -29,089 | -7,816 |
| Capital Expenditure | -1,001 | -3,532 | -24,116 | -18,682 | -2,257 |
| Free Cash Flow | -18,108 | -14,034 | -48,884 | -47,772 | -10,073 |